Dimebon . 2HCl

Antihistamine with cognition-enhancing properties



BML-NH112-0010	10 mg	155.00 USD

BML-NH112-0050	50 mg	618.00 USD

Antihistamine that possesses cognition-enhancing properties. Blocks mitochondrial permeability transition pore opening induced by MPP⁺ and β-amyloid. Has been shown to interact with a number of molecular targets including acetylcholinesterases, NMDA receptors and L-type calcium channels as well as acting as an antagonist at 5-HT6 receptors. Dimebon significantly improved the clinical course of patients with mild-to-moderate Alzheimer’s disease in a randomized, double-blind, placebo-controlled study.

Product Specification

Alternative Name:	2,3,4,5-Tetrahydro-2,8-dimethyl-5-(2-(6-methyl-3-pyridyl)ethyl)-1H-pyrido(4,3-b)indole . 2HCl

Formula:	C₂₁H₂₅N₃ . 2HCl

MW:	319.4 . 73.0

Purity:	≥98% (TLC)

Appearance:	Off-white/pale purple solid.

CAS:	97657-92-6

Solubility:	Soluble in water (>25mg/ml) or DMSO (10mg/ml).

Long Term Storage:	+20°C

Use/Stability:	Store solutions at -20°C for up to 3 months.

Hazard:	HARMFUL.

Background / Technical Information:	Please click here for the comprehensive product data sheet.

Please mouse over

Product Literature References

Dimebolin is a 5-HT6 antagonist with acute cognition enhancing activities: H. Schaffhauser, et al.; Biochem. Pharmacol. 78, 1035 (2009), Abstract;

Effect of dimebon on cognition, activities of daily living, behaviour, and global function in patients with mild-to-moderate Alzheimer’s disease: a randomised, double-blind, placebo-controlled study: R.S. Doody, et al.; Lancet 372, 207 (2008), Abstract;

Mitochondria as a target for neurotoxins and neuroprotective agents: S.O. Bachurin, et al.; Ann. N.Y. Acad. Sci. 993, 334 (2003), Abstract;

Antihistamine agent Dimebon as a novel neuroprotector and a cognition enhancer: S. Bachurin, et al.; Ann. N.Y. Acad. Sci. 939, 425 (2001), Abstract;